飛鹿股份(300665.SZ):擬繼續使用不超2000萬元閒置募集資金暫補流動資金
格隆匯5月28日丨飛鹿股份(300665.SZ)公佈,公司於2021年5月28日召開第四屆董事會第二次會議、第四屆監事會第二次會議,審議通過了《關於繼續使用部分閒置募集資金暫時補充流動資金的議案》,同意在保證募集資金投資項目建設的資金需求、保證募集資金投資項目正常進行的前提下,公司使用不超過人民幣2000萬元(含2000萬元)的閒置募集資金用於暫時補充流動資金,使用期限自董事會審批通過之日起不超過6個月。到期將歸還至募集資金專户。本次使用部分閒置募集資金補充流動資金事項無需提交股東大會審議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.